The Molecular Pathology Shared Resource (MPSR) is the largest shared resource of the Herbert Irving Comprehensive Cancer Center, serving 379 Pi's since 2007 and 193 Pi's this year (2013), with charge backs of ~$80K/month and 17,828 service requests fulfilled since 2007.
Its aim i s to facilitate tissue-based research so as to accelerate the realization of the great potential of the post-genomic era in cancer research. We provide our researchers a diverse set of services, including tumor banking, histology and immunohistochemistry, full pathological evaluation of human material and mouse models, traditional and "next generation" (nucleic acids-based) tumor banking, as well as start-to-finish tissue-based research project management. Importantly, in close collaboration with the new Database SR, we help with data clawing (treatment, survival), data de-Identification and data storage, so that our banked material is well annotated and extremely valuable for clinical correlative studies. The MPSR has expanded its services recently to include whole slide scanning, storage and analysis (Leica SCN 400), high throughput RNA/DNA extraction capability (QIAsymphony SP), and fee-for-service project management, which is particularly valuable for clinicians who may not have their own research laboratory staff. Accordingly, the MPSR has played and continues to play a pivotal and ubiquitous role in enabling the HICCC research enterprise. The total operating budget of the facility is $1,193,178 of which we are requesting $ 118,178 from the CCSG
The need to extract information from cancer and normal tissues has dramatically increased as high throughput technology and economically feasible TCGA-type multi-omic analysis, along with ever improving mouse models of cancer, are all bearing fruit. Our solutions are specifically geared to enable the full spectrum of basic and clinical cancer researchers to test their insights at the primary tissue level, efficiently and cost effectively, through ready access to tissue and RNA/DNA banks, services/expertise and associated technologies.
|Bassuk, Alexander G; Sujirakul, Tharikarn; Tsang, Stephen H et al. (2014) A novel RPGR mutation masquerading as Stargardt disease. Br J Ophthalmol 98:709-11|
|Li, Yao; Wu, Wen-Hsuan; Hsu, Chun-Wei et al. (2014) Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 22:1688-97|
|Wert, Katherine J; Sancho-Pelluz, Javier; Tsang, Stephen H (2014) Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet 23:514-23|
|Shen, Sherry; Sujirakul, Tharikarn; Tsang, Stephen H (2014) Next-generation sequencing revealed a novel mutation in the gene encoding the beta subunit of rod phosphodiesterase. Ophthalmic Genet 35:142-50|
|Palomero, Teresa; Couronné, Lucile; Khiabanian, Hossein et al. (2014) Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 46:166-70|
|Higuchi-Sanabria, Ryo; Pernice, Wolfgang M A; Vevea, Jason D et al. (2014) Role of asymmetric cell division in lifespan control in Saccharomyces cerevisiae. FEMS Yeast Res 14:1133-46|
|Lam, A T; Curschellas, C; Krovvidi, D et al. (2014) Controlling self-assembly of microtubule spools via kinesin motor density. Soft Matter 10:8731-6|
|Olszak, Torsten; Neves, Joana F; Dowds, C Marie et al. (2014) Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509:497-502|
|Murtomaki, Aino; Uh, Minji K; Kitajewski, Chris et al. (2014) Notch signaling functions in lymphatic valve formation. Development 141:2446-51|
|Nong, Eva; Lee, Winston; Merriam, Joanna E et al. (2014) Disease progression in autosomal dominant cone-rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene. Doc Ophthalmol 128:59-67|
Showing the most recent 10 out of 142 publications